These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9760451)

  • 1. Genetic polymorphism of conjugating enzymes and cancer risk: GSTM1, GSTT1, NAT1 and NAT2.
    Lee E; Huang Y; Zhao B; Seow-Choen F; Balakrishnan A; Chan SH
    J Toxicol Sci; 1998 Jul; 23 Suppl 2():140-2. PubMed ID: 9760451
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.
    Kiss I; Németh A; Bogner B; Pajkos G; Orsós Z; Sándor J; Csejtey A; Faluhelyi Z; Rodler I; Ember I
    Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No association between genetic polymorphisms of CYP1A1, GSTM1, GSTT1, GSTP1, NAT2, and nasopharyngeal carcinoma in Taiwan.
    Cheng YJ; Chien YC; Hildesheim A; Hsu MM; Chen IH; Chuang J; Chang J; Ma YD; Luo CT; Hsu WL; Hsu HH; Huang H; Chang JF; Chen CJ; Yang CS
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):179-80. PubMed ID: 12582034
    [No Abstract]   [Full Text] [Related]  

  • 4. No modifying effect of NAT1, GSTM1, and GSTT1 on the relation between smoking and colorectal cancer risk.
    van der Hel OL; Bueno de Mesquita HB; Roest M; Slothouber B; van Gils C; van Noord PA; Grobbee DE; Peeters PH
    Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):681-2. PubMed ID: 12869413
    [No Abstract]   [Full Text] [Related]  

  • 5. [Genetic polymorphism of gluthation-S transferases and N-acetyl transferases 2 and nasopharyngeal carcinoma: the Tunisia experience].
    Bendjemana K; Abdennebi M; Gara S; Jmal A; Ghanem A; Touati S; Boussen H; Ladgham A; Guemira F
    Bull Cancer; 2006 Mar; 93(3):297-302. PubMed ID: 16567317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in GSTP1, GSTM1, and GSTT1 and susceptibility to colorectal cancer.
    Welfare M; Monesola Adeokun A; Bassendine MF; Daly AK
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):289-92. PubMed ID: 10207630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer.
    Bell DA; Stephens EA; Castranio T; Umbach DM; Watson M; Deakin M; Elder J; Hendrickse C; Duncan H; Strange RC
    Cancer Res; 1995 Aug; 55(16):3537-42. PubMed ID: 7627961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of DNA and protein adducts in smokers by genetic polymorphisms in GSTM1,GSTT1, NAT1 and NAT2.
    Godschalk RW; Dallinga JW; Wikman H; Risch A; Kleinjans JC; Bartsch H; Van Schooten FJ
    Pharmacogenetics; 2001 Jul; 11(5):389-98. PubMed ID: 11470992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of GSTT1, GSTM1, GSTP1 and NAT2 genotypes on KRAS2 and TP53 gene mutations in colorectal cancer.
    Ferraz JM; Zinzindohoué F; Lecomte T; Cugnenc PH; Loriot MA; Beaune P; Stücker I; Berger A; Laurent-Puig P
    Int J Cancer; 2004 Jun; 110(2):183-7. PubMed ID: 15069679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione S-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk: a prospective study.
    Gertig DM; Stampfer M; Haiman C; Hennekens CH; Kelsey K; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1001-5. PubMed ID: 9829708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer.
    Lee KM; Park SK; Kim SU; Doll MA; Yoo KY; Ahn SH; Noh DY; Hirvonen A; Hein DW; Kang D
    Cancer Lett; 2003 Jul; 196(2):179-86. PubMed ID: 12860276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma.
    Moore LE; Huang WY; Chatterjee N; Gunter M; Chanock S; Yeager M; Welch B; Pinsky P; Weissfeld J; Hayes RB
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1823-7. PubMed ID: 16030123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer.
    Olshan AF; Weissler MC; Watson MA; Bell DA
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):185-91. PubMed ID: 10698480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.
    Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E
    Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between metabolic enzyme polymorphism and colorectal cancer.
    Chen K; Jiang QT; He HQ
    World J Gastroenterol; 2005 Jan; 11(3):331-5. PubMed ID: 15637738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of N-acetyltransferase-2 and glutathione S-transferase on the risk and aggressiveness of bladder cancer.
    Giannakopoulos X; Charalabopoulos K; Baltogiannis D; Chatzikiriakidou A; Alamanos Y; Georgiou I; Evangelou A; Agnantis N; Sofikitis N
    Anticancer Res; 2002; 22(6B):3801-4. PubMed ID: 12552997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphism of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern India.
    Srivastava DS; Mandhani A; Mittal B; Mittal RD
    BJU Int; 2005 Jan; 95(1):170-3. PubMed ID: 15638917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arylamine N-acetyltransferase type 2 and glutathione S-transferases M1 and T1 polymorphisms in familial adenomatous polyposis.
    Lamberti C; Jungck M; Laarmann M; Knapp M; Caspari R; Friedl W; Sauerbruch T; Propping P; Kruse R
    Pharmacogenetics; 2002 Jan; 12(1):49-54. PubMed ID: 11773864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetyl transferase 1: two polymorphisms in coding sequence identified in colorectal cancer patients.
    Hubbard AL; Moyes C; Wyllie AH; Smith CA; Harrison DJ
    Br J Cancer; 1998 Mar; 77(6):913-6. PubMed ID: 9528834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer.
    Sachse C; Smith G; Wilkie MJ; Barrett JH; Waxman R; Sullivan F; Forman D; Bishop DT; Wolf CR;
    Carcinogenesis; 2002 Nov; 23(11):1839-49. PubMed ID: 12419832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.